WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · HB 325

Legislative bill overview

HB 325 modifies Hawaii's medical cannabis program, though the specific amendments are not detailed in the provided legislative history. The bill passed the Labor & Public Empowerment (LAB) committee with amendments and advanced to further consideration before being carried over to the 2026 session. The measure received broad support in committee with six affirmative votes and one dissenting vote.

Why is this important

Medical cannabis policy affects patient access to treatment options, regulatory frameworks for dispensaries, and tax revenue for the state. Hawaii's medical cannabis program directly impacts patients with qualifying conditions and the businesses operating within the legal framework, making procedural changes potentially significant for stakeholders.

Potential points of contention

  • The specific amendments made in HD 1 are not publicly detailed in this summary, making it unclear what regulatory, licensing, or access changes are proposed
  • One representative voted against passage, suggesting at least some legislative opposition to the bill's provisions
  • The carryover to 2026 indicates the measure did not reach final passage in 2025, potentially reflecting unresolved concerns or competing priorities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.